Retrasib reported earnings results for the first half of 2014. For the period, the company reported a net loss of RON 2.2 million ($663,100/EUR 495,300) compared to a loss of RON 500,000 a year earlier. Net turnover was RON 12.9 million compared to RON 11.2 million a year ago.

Total revenue was RON 13 million compared to RON 19.4 million a year ago.